Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
0.9532
-0.0468 (-4.68%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Pluri Market Cap
Pluri has a market cap or net worth of $11.77 million as of October 9, 2026. It is the 40,717th most valuable company in the world and the 5,555th biggest in the United States. Its market cap has decreased by 64.66% in one year.
Market Cap
11.77M
Enterprise Value
38.88M
1-Year Change
-64.66%
Global Rank
Country Rank
#5,555 United States
Category
ChartMarket Cap Chart
Since December 10, 2007, Pluri's market cap has decreased from $36.10M to $11.77M, a decrease of -67.40%. That is a compound annual growth rate of -5.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 11.80M | -57.40% |
| Dec 31, 2025 | 27.70M | 16.39% |
| Dec 31, 2024 | 23.80M | -0.83% |
| Dec 29, 2023 | 24.00M | -21.82% |
| Dec 30, 2022 | 30.70M | -34.54% |
| Dec 31, 2021 | 46.90M | -74.12% |
| Dec 31, 2020 | 181.20M | 192.73% |
| Dec 31, 2019 | 61.90M | -32.20% |
| Dec 31, 2018 | 91.30M | -38.81% |
| Dec 29, 2017 | 149.20M | 28.73% |
| Dec 30, 2016 | 115.90M | 29.35% |
| Dec 31, 2015 | 89.60M | -48.86% |
| Dec 31, 2014 | 175.20M | -16.89% |
| Dec 31, 2013 | 210.80M | 15.13% |
| Dec 31, 2012 | 183.10M | 67.98% |
| Dec 30, 2011 | 109.00M | 189.89% |
| Dec 31, 2010 | 37.60M | 74.88% |
| Dec 31, 2009 | 21.50M | 532.35% |
| Dec 31, 2008 | 3.40M | -84.62% |
| Dec 31, 2007 | 22.10M | -38.78% |
| Dec 10, 2007 | 36.10M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 13.06M |
| Tempest Therapeutics | 12.95M |
| Cerenome | 12.67M |
| Daré Bioscience | 12.30M |
| Intensity Therapeutics | 11.92M |
| Lantern Pharma | 11.60M |
| Phio Pharmaceuticals | 11.38M |
| GT Biopharma | 11.35M |